1-3 of 3
Jean Marc Schiano
Close
Sort by
Journal Articles

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group

Clinical Trials & Observations
Raphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, Charles Herbaux, Anne Banos, Pauline Brice, David Sibon, Jean Marc Schiano, Thomas Cluzeau, Kamel Laribi, Ronan Le Calloch, Mathieu Bellal, Baptiste Delapierre, Nicolas Daguindau, Sandy Amorim, Kossi Agbetiafa, Adrien Chauchet, Caroline Besson, Eric Durot, Christophe Bonnet, Ludovic Fouillet, Fontanet Bijou, Olivier Tournilhac, Philippe Gaulard, Marie-Cécile Parrens, Gandhi Damaj
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5733–5742.
https://doi.org/10.1182/bloodadvances.2022008524
Published: 2023
Includes: Supplemental data
Journal Articles

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group

Yassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, Emmanuel Bachy, Emmanuelle Nicolas-Virelizier, Jean Marc Schiano De colella, Clement Bailly, Salim Kanoun, Stéphanie Guidez, Emmanuel Gyan, Remy Gressin, Nadine Morineau, Loic Ysebaert, Steven Le Gouill, Herve Tilly, Roch Houot, F. Morschhauser, Guillaume Cartron, Charles Herbaux
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3735–3738.
https://doi.org/10.1182/bloodadvances.2023009911
Published: 2023
Includes: Supplemental data
Journal Articles

ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells

Florent Amatore, Nicolas Ortonne, Marc Lopez, Florence Orlanducci, Rémy Castellano, Saskia Ingen-Housz-Oro, Amandine De Croos, Clémentine Salvado, Laurent Gorvel, Armelle Goubard, Yves Collette, Réda Bouabdallah, Jean-Marc Schiano, Nathalie Bonnet, Jean-Jacques Grob, Philippe Gaulard, Martine Bagot, Armand Bensussan, Philippe Berbis, Daniel Olive
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5203–5214.
https://doi.org/10.1182/bloodadvances.2020002395
Published: 2020
Includes: Supplemental data